Browse studies

Find your next paid study

27,270 recruiting studies available now

A Randomized, Double-blind, Parallel-arm, Sham-controlled Trial of ElectraRx Mindfulness Transcranial Direct Current Treatment System (Elect-MDS) for Adults With Major Depressive Disorder

This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol…

Unipolar Depression

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Soterix MedicalNCT07042217

Observational

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the tre…

COPDEmphysema

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Apreo Health, Inc.NCT06891755

Phase 2

Dynamic Assessments of Molecular Response to Guide Early 177Lu-PSMA-617 Treatment Discontinuation: The DYNAMO Study

This clinical trial studies whether measuring circulating tumor deoxyribonucleic acid (ctDNA) tumor fraction (TF) can be used to help guide the early stopping …

Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of WashingtonNCT07698535

Characteristics And Clinical Course Of Disease In Participants With Cardiomyopathy Associated With Friedreich Ataxia (CLARITY-FA)

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Friedreich AtaxiaCardiomyopathy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Lexeo TherapeuticsNCT06865482

Phase 3

A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Gastric or Esophageal Cancer

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic dise…

Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SOFIENCT07217704

An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber

The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFibe…

OsteoFlo HydroFiber

Estimated

~$10 – $1,050

Actual pay is set by the research site.

SurGenTec LLCNCT07784673

Phase 3

An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy

The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatme…

Breast Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07062965

Observational

Postpartum Care in the NICU (PeliCaN) for Maternal Wellbeing and Breastfeeding

Parents of infants in the neonatal intensive care unit (NICU) face unique barriers to long-term breastfeeding and lactation. The physical and emotional demands…

Postpartum ComplicationPostpartumPTSD+6 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT07881731

Feasibility of the Investigational Nellcor™ Investigational Device During Non-Motion and Walking Motion Conditions in Adult Volunteers

To examine pulse rate and blood oxygen saturation accuracy of the Nellcor™ Investigational Device during non-motion and walking motion conditions in a diverse …

Oxygen Saturation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Medtronic - MITGNCT07234279

Phase 1

A Two-Part, Phase 1, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and WISPER Target Engagement of HTX-001 in Adult Healthy Participants (Part 1) and in Adult Participants With Nonobstructive Hypertrophic Cardiomyopathy (Part 2)

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HTX-001 in human adult participants.

Nonobstructive Hypertrophic Cardiomyopathy

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Haya Therapeutics, Inc.NCT07867288

Phase 1

A Phase 1b/2, Open-label, Multi-center Study to Evaluate the Anti-cancer Activity, Safety and Tolerability of GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig [T-CELL-Redirecting Agent Targeting Human Kallikrein 2 (KLK2)] in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Progressed on Previous Novel Hormonal Therapy (NHT) (JET-201)

The purpose of this clinical trial is to evaluate the safety, tolerability, and preliminary anti-cancer activity of GI-102 in combination with pasritamig in ad…

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

GI Innovation, Inc.NCT07871435

Observational

A Prospective Randomized Unblinded Study of Ketogenetic Versus Mixed Diet on Exercise Tolerance in Subjects With the Metabolic Phenotype of Heart Failure With Preserved Ejection Fraction

This study is being done to evaluate the effects of a low carbohydrate ketogenic diet (KD) versus a low-fat diet (MD) on exercise tolerance in participants wit…

Heart Failure With Preserved Ejection Fraction

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State UniversityNCT06081543